A Study of HX008 for the Treatment of Patients With Malignant Melanoma

NCT04749485 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: HX008

Sponsor

Taizhou Hanzhong biomedical co. LTD